Imbalance between soluble tumour necrosis factor receptors type 1 and 2 in chronic periodontitis

被引:32
作者
Ikezawa, I [1 ]
Tai, H [1 ]
Shimada, Y [1 ]
Komatsu, Y [1 ]
Galicia, JC [1 ]
Yoshie, H [1 ]
机构
[1] Niigata Univ, Grad Sch Med & Dent Sci, Div Periodontol, Niigata 9518514, Japan
关键词
chronic periodontitis; gingival crevicular fluid; serum; soluble tumour necrosis factor receptor; tumour necrosis factor-alpha;
D O I
10.1111/j.1600-051X.2005.00832.x
中图分类号
R78 [口腔科学];
学科分类号
1003 ;
摘要
Background: Soluble types of tumour necrosis factor (TNF) receptors type I and 2 modulate the TNF-alpha-mediated inflammatory responses in chronic periodontitis (CP). Objectives: This study investigated the levels of TNF-alpha, soluble TNF receptor type 1 and 2 in gingival crevicular fluid (GCF) and serum of healthy subjects and CP patients. Materials and Methods: Thirty-eight sera and 73 GCF samples were collected from 16 healthy subjects and 22 CP patients. GCF was collected from probing pocket depth (PPD) <= 3 rum sites of healthy subjects, PPD <= 3, 4-6 and >= 7 mm sites of CP patients. The levels of TNF-a, soluble TNF receptor type 1 and 2 in the serum and GCF were quantified by enzyme-linked immunosorbant assay. Results: The total amounts of TNF-alpha, soluble TNF receptor type I and 2 in GCF significantly elevated with increasing PPD in both site-based (p < 0.05) and subject-based (p < 0.05) analyses. However, their levels progressively diverged as the pocket depths increased, with the soluble TNF receptor type 2 level being comparatively lower than type 1. On the other hand, soluble TNF receptor type 2/type 1 ratios in GCF decreased as the severity of periodontitis increased (p < 0.0001). Conclusion: The imbalance between soluble TNF receptor type I and 2 levels in GCF could be related to CP severity.
引用
收藏
页码:1047 / 1054
页数:8
相关论文
共 25 条
  • [1] Aderka Dan, 1996, Cytokine and Growth Factor Reviews, V7, P231, DOI 10.1016/S1359-6101(96)00026-3
  • [2] Arno A, 1959, J PERIODONTOL, V30, P7, DOI [10.1902/jop.1959.30.1.7, DOI 10.1902/JOP.1959.30.1.7]
  • [3] Assuma R, 1998, J IMMUNOL, V160, P403
  • [4] INCREASED LEVELS OF SOLUBLE TUMOR-NECROSIS-FACTOR RECEPTORS IN THE SERA AND SYNOVIAL-FLUID OF PATIENTS WITH RHEUMATIC DISEASES
    COPE, AP
    ADERKA, D
    DOHERTY, M
    ENGELMANN, H
    GIBBONS, D
    JONES, AC
    BRENNAN, FM
    MAINI, RN
    WALLACH, D
    FELDMANN, M
    [J]. ARTHRITIS AND RHEUMATISM, 1992, 35 (10): : 1160 - 1169
  • [5] Soluble antagonists to interleukin-1 (IL-1) and tumor necrosis factor (TNF) inhibits loss of tissue attachment in experimental periodontitis
    Delima, AJ
    Oates, T
    Assuma, R
    Schwartz, Z
    Cochran, D
    Amar, S
    Graves, DT
    [J]. JOURNAL OF CLINICAL PERIODONTOLOGY, 2001, 28 (03) : 233 - 240
  • [6] The influence of interleukin gene polymorphism on expression of interleukin-1β and tumor necrosis factor-α in periodontal tissue and gingival crevicular fluid
    Engebretson, SP
    Lamster, IB
    Herrera-Abreu, M
    Celenti, RS
    Timms, JM
    Chaudhary, AGA
    di Giovine, FS
    Kornman, KS
    [J]. JOURNAL OF PERIODONTOLOGY, 1999, 70 (06) : 567 - 573
  • [7] Delayed neutrophil apoptosis in chronic periodontitis patients
    Gamonal, J
    Sanz, M
    O'Connor, A
    Acevedo, A
    Suarez, I
    Sanz, A
    Martínez, B
    Silva, A
    [J]. JOURNAL OF CLINICAL PERIODONTOLOGY, 2003, 30 (07) : 616 - 623
  • [8] Etanercept: therapeutic use in patients with rheumatoid arthritis
    Garrison, L
    McDonnell, ND
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 1999, 58 : 65 - 69
  • [9] Interleukin-1 and tumor necrosis factor antagonists inhibit the progression of inflammatory cell infiltration toward alveolar bone in experimental periodontitis
    Graves, DT
    Delima, AJ
    Assuma, R
    Amar, S
    Oates, T
    Cochran, D
    [J]. JOURNAL OF PERIODONTOLOGY, 1998, 69 (12) : 1419 - 1425
  • [10] HAYASHI H, 2003, J TOKYO MED U, V61, P248